All Featured Insights

Hospital financial performance remained relatively stable during the month of August, and despite higher patient volume, revenue and expenses declined on a volume-adjusted basis.

HRSA warns Johnson & Johnson over 340B restrictions, a group of hospitals sues HHS to overturn DSH payment changes, and a CHS subsidiary expands its urgent care network.

This week’s graphic uses health system size and performance data from the Agency for Healthcare Research and Quality to illustrate what it means to be an average health system.

This week’s graphic highlights data from NSI Nursing Solutions, Inc., and details the current state of hospital turnover and nursing talent retention.

The White House finalizes mental health parity rules, CMS notifies 1M beneficiaries of data breach, and Humana is exiting 13 MA markets.

Hospital financial performance remains strong this year, with continued stabilization in the month of July. Outpatient revenue and average lengths of stay showed signs of improvement.

In a recent Becker’s Healthcare Podcast episode, Ken Kaufman, joined Scott Becker to discuss critical trends in healthcare finance, the impact of COVID-19 on hospital operations, and the challenges of consolidation and staffing in the healthcare industry.

The latest Kaufman Hall National Hospital Flash Report shows that the Calendar Year to Date Operating Margin Index for hospitals was 4.1% in June.

Health systems are confronting a new normal of shrinking revenue and rising labor costs. In the second quarter of 2024, increased labor expenses accounted for 83.9% of total expenses. Additionally, the median investment/subsidy per provider rose 3% since Q2 2023.

Hospital financial performance remained relatively unchanged during the month of May, and the rate of change slowed for margins and other key performance indicators, which reflects stabilization.

Hospital financial performance improved in April relative to both March and the same time frame last year, though a closer examination of the data shows a greater difference in performance at the hospital level.

Ozempic trial shows the drug slows kidney disease progression, a blood-based colorectal cancer test is endorsed for FDA approval, and nursing home trade groups sue over the new staffing mandate.